Dr Kai Dun Tang obtained a PhD degree in late 2015 from Queensland University of Technology (QUT), focusing on the study of tumour microenvironment and metastasis using both animal and tissue engineering models. He began his academic career as an early career postdoctoral researcher, concentrating on the development of diagnostic and prognostic biomarkers for head and neck cancer using blood and saliva in the lab of A/Professor Punyadeera at QUT/ Institute of Health Biomedical Innovation (IHBI), in close collaboration with Janssen: Pharmaceutical Companies of Johnson & Johnson.
Presentation Title: A “needleless” approach to detect HPV-driven head and neck cancer
There has been a dramatic rise in the incidence of human papillomavirus (HPV)-driven head and neck cancer (HNC) in the developed countries, including Australia. In addition, HNC biopsy collection is challenging compared to other tumor types due to the fact that the tumours are usually microscopic and inconspicuous. Owing to its close proximity to the oral cavity, saliva has been suggested as a non-invasive medium for HNC. The ultimate goal of this study is to develop a quick, affordable, and accurate test to detect individuals at risk of developing HNC using saliva samples, which may facilitate early clinical decision making.